HCV Virus and Lymphoid Neoplasms
Authors:
Open Access
- 5 July 2011
- journal article
- review article
- Published by Hindawi Limited in Advances in Hematology
- Vol. 2011, 1-6
Abstract
Hepatitis C virus (HCV) is one of the viruses known to cause hepatic cancer. HCV is also believed to be involved in malignant lymphoma. In this paper, we investigated characteristics of malignant lymphoma cases that were anti-HCV antibody (HCV-Ab) positive. We were able to perform pathological examinations on 13 out of 14 HCV-positive cases. Of these, lymphoid tissues of 10 stained positive for HCV-Ab. There was no significant correlation between the degree of HCV staining and the rate of recurrence or resistance to treatment. However, there did appear to be a consistent decrease in the amount of HCV-RNA between pre- and posttreatment among HCV-Ab-positive cases; that is, treatment-resistant cases that exhibited resistance from the first treatment and recurrent cases more frequently had a higher HCV level at treatment termination compared to the pretreatment level. This suggests that the HCV virus either accelerates oncogenesis by direct interaction with B cells or indirectly affects lymphoma prognosis.Keywords
This publication has 26 references indexed in Scilit:
- HCV genotype 2 as a risk factor for reactivation in patients with B‐cell lymphoma undergoing rituximab combination chemotherapyBritish Journal of Haematology, 2010
- Isoform‐selective phosphoinositide 3‐kinase inhibitors induce apoptosis in chronic lymphocytic leukaemia cellsBritish Journal of Haematology, 2010
- Hepatitis C and Lymphoproliferative Disorders: From Mixed Cryoglobulinemia to Non-Hodgkin's LymphomaClinical Gastroenterology and Hepatology, 2009
- Changes in hepatitis C virus antibody titer and viral RNA load in non-Hodgkin’s lymphoma patients after rituximab chemotherapyInternational Journal of Laboratory Hematology, 2009
- Hematopoietic Malignancies Associated with Viral and Alcoholic HepatitisCancer Epidemiology, Biomarkers & Prevention, 2008
- Hepatocellular carcinoma and other primary liver cancers in hepatitis C patients in Sweden – a low endemic countryJournal of Viral Hepatitis, 2008
- Hepatitis C virus and lymphomaJournal of Clinical Pathology, 2007
- Hepatitis C Virus and Risk of Lymphoma and Other Lymphoid Neoplasms: A Meta-analysis of Epidemiologic StudiesCancer Epidemiology, Biomarkers & Prevention, 2006
- Cancer incidence in people with hepatitis B or C infection: A large community-based linkage studyJournal of Hepatology, 2006
- Role of Anti-Hepatitis C Virus (HCV) Treatment in HCV-Related, Low-Grade, B-Cell, Non-Hodgkin's Lymphoma: A Multicenter Italian ExperienceJournal of Clinical Oncology, 2005